Actions of two new antagonists showing selectivity for different sub-types of metabotropic glutamate receptor in the neonatal rat spinal cord - PubMed (original) (raw)
Actions of two new antagonists showing selectivity for different sub-types of metabotropic glutamate receptor in the neonatal rat spinal cord
D E Jane et al. Br J Pharmacol. 1994 Jul.
Abstract
1. The presynaptic depressant action of L-2-amino-4-phosphonobutyrate (L-AP4) on the monosynaptic excitation of neonatal rat motoneurones has been differentiated from the similar effects produced by (1S,3R)-1-aminocyclopentane-1,3-dicarboxylate ((1S,3R)-ACPD), (1S,3S)-ACPD and (2S,3S,4S)-alpha-(carboxycyclopropyl)glycine (L-CCG-I), and from the postsynaptic motoneuronal depolarization produced by (1S,3R)-ACPD, by the actions of two new antagonists, alpha-methyl-L-AP4 (MAP4) and alpha-methyl-L-CCG-I (MCCG). Such selectivity was not seen with a previously reported antagonist, (+)-alpha-methyl-4-carboxyphenylglycine (MCPG). 2. MAP4 selectively and competitively antagonized the depression of monosynaptic excitation produced by L-AP4 (KD 22 microM). At ten fold higher concentrations, MAP4 also antagonized synaptic depression produced by L-CCG-I but in an apparently non-competitive manner. MAP4 was virtually without effect on depression produced by (1S,3R)- or (1S,3S)-ACPD. 3. MCCG differentially antagonized the presynaptic depression produced by the range of agonists used. This antagonist had minimal effect on L-AP4-induced depression. The antagonism of the synaptic depression effected by (1S,3S)-ACPD and L-CCG-I was apparently competitive in each case but of varying effectiveness, with apparent KD values for the interaction between MCCG and the receptors activated by the two depressants calculated as 103 and 259 microM, respectively. MCCG also antagonized the presynaptic depression produced by (1S,3R)-ACPD. 4. Neither MAP4 nor MCCG (200-500 microM) significantly affected motoneuronal depolarizations produced by (1S,3R)-ACPD. At the same concentrations the two antagonists produced only very weak and variable effects (slight antagonism or potentiation) on depolarizations produced by (S)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) and N-methyl-D-aspartate (NMDA).5. It is concluded that MAP4 is a potent and selective antagonist for those excitatory amino acid(EAA) receptors on neonatal rat primary afferent terminals that are preferentially activated by L-AP4,and that MCCG is a relatively selective antagonist for different presynaptic EAA receptors that are preferentially activated by (1S,3S)-ACPD and (perhaps less selectively) by L-CCG-I. These receptors probably comprise two sub-types of metabotropic glutamate receptors negatively linked to adenylyl cyclase activity.
Similar articles
- Pharmacological antagonism of the actions of group II and III mGluR agonists in the lateral perforant path of rat hippocampal slices.
Bushell TJ, Jane DE, Tse HW, Watkins JC, Garthwaite J, Collingridge GL. Bushell TJ, et al. Br J Pharmacol. 1996 Apr;117(7):1457-62. doi: 10.1111/j.1476-5381.1996.tb15306.x. Br J Pharmacol. 1996. PMID: 8730739 Free PMC article. - Potent antagonists at the L-AP4- and (1S,3S)-ACPD-sensitive presynaptic metabotropic glutamate receptors in the neonatal rat spinal cord.
Jane DE, Thomas NK, Tse HW, Watkins JC. Jane DE, et al. Neuropharmacology. 1996;35(8):1029-35. doi: 10.1016/s0028-3908(96)00048-2. Neuropharmacology. 1996. PMID: 9121605 - A novel metabotropic glutamate receptor agonist: marked depression of monosynaptic excitation in the newborn rat isolated spinal cord.
Ishida M, Saitoh T, Shimamoto K, Ohfune Y, Shinozaki H. Ishida M, et al. Br J Pharmacol. 1993 Aug;109(4):1169-77. doi: 10.1111/j.1476-5381.1993.tb13745.x. Br J Pharmacol. 1993. PMID: 8401927 Free PMC article. - A metabotropic L-glutamate receptor agonist: pharmacological difference between rat central neurones and crayfish neuromuscular junctions.
Shinozaki H, Ishida M. Shinozaki H, et al. Comp Biochem Physiol C Comp Pharmacol Toxicol. 1992 Sep;103(1):13-7. doi: 10.1016/0742-8413(92)90220-2. Comp Biochem Physiol C Comp Pharmacol Toxicol. 1992. PMID: 1360366 Review. - [Pharmacology of the glutamate receptor].
Shinozaki H. Shinozaki H. Nihon Yakurigaku Zasshi. 2000 Sep;116(3):125-31. doi: 10.1254/fpj.116.125. Nihon Yakurigaku Zasshi. 2000. PMID: 11031741 Review. Japanese.
Cited by
- Metabotropic glutamate receptors promote disinhibition of olfactory bulb glomeruli that scales with input strength.
Zak JD, Whitesell JD, Schoppa NE. Zak JD, et al. J Neurophysiol. 2015 Mar 15;113(6):1907-20. doi: 10.1152/jn.00222.2014. Epub 2014 Dec 31. J Neurophysiol. 2015. PMID: 25552635 Free PMC article. - Group III metabotropic glutamate receptors: pharmacology, physiology and therapeutic potential.
Mercier MS, Lodge D. Mercier MS, et al. Neurochem Res. 2014 Oct;39(10):1876-94. doi: 10.1007/s11064-014-1415-y. Epub 2014 Aug 22. Neurochem Res. 2014. PMID: 25146900 Review. - Activation of group I metabotropic glutamate receptors depresses recurrent inhibition of motoneurons in the neonatal rat spinal cord in vitro.
Marchetti C, Taccola G, Nistri A. Marchetti C, et al. Exp Brain Res. 2005 Jul;164(3):406-10. doi: 10.1007/s00221-005-2368-9. Epub 2005 Jul 1. Exp Brain Res. 2005. PMID: 15991027 - Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor alpha-induced neurotoxicity in concert with microglial-derived Fas ligand.
Taylor DL, Jones F, Kubota ES, Pocock JM. Taylor DL, et al. J Neurosci. 2005 Mar 16;25(11):2952-64. doi: 10.1523/JNEUROSCI.4456-04.2005. J Neurosci. 2005. PMID: 15772355 Free PMC article. - Asymmetric hydrogenation of alpha,beta-unsaturated phosphonates with Rh-BisP* and Rh-MiniPHOS catalysts: scope and mechanism of the reaction.
Gridnev ID, Yasutake M, Imamoto T, Beletskaya IP. Gridnev ID, et al. Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5385-90. doi: 10.1073/pnas.0306993101. Epub 2004 Mar 15. Proc Natl Acad Sci U S A. 2004. PMID: 15024119 Free PMC article.
References
- Br J Pharmacol. 1982 Jan;75(1):65-75 - PubMed
- Eur J Pharmacol. 1994 Jan 15;266(2):187-92 - PubMed
- Neuron. 1992 Jan;8(1):169-79 - PubMed
- Exp Physiol. 1992 May;77(3):529-32 - PubMed
- Science. 1992 Oct 23;258(5082):597-603 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources